Advertisement

Search Results for "novartis"

Forbes List Logo
Anticipation Within Novartis
What is a guy who spent eight years selling food for Heinz doing at the top of the world's best research-based drug company? Preparing for the worst
ByMatthew Herper
Inside Vasant 'Vas' Narasimhan's transformation of Novartis, and more
ByBrian Carvalho
Novartis: Innovating for the world, from India
ByManu Balachandran
Novartis will start doing more fundamental research work in India: Vas Narasimhan
ByManu Balachandran
Inside Novartis' outsized play in India
ByManu Balachandran
From Novartis' turnaround to everything you should know about studying abroad, here are our top reads of the week
ByForbes India
Can Novartis Chief Joseph Jimenez Cure Cancer?
ByMatthew Herper
Novartis will pay a $678 million settlement for doctor kickbacks
Why Indian pharma needs to elevate ESG for sustainable future
ByISB
AI is increasing demand for managers - and changing their skill sets
ByIESE Business School
Global pharma: Focus on core business, pure-play innovation
ByNaini Thaker
Storyboard18 | Time is ripe to take advantage of the growing cult of Made-In-India CEOs
ByLloyd Mathias
Investing beyond borders: Risk or opportunity?
ByRamesh Sadhwani

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement